Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
10%
Ph phase_4
1
10%
Ph not_applicable
8
80%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(6)
Completed(3)
Other(1)

Detailed Status

Not yet recruiting5
Completed3
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

unknown110%
completed330%
active_not_recruiting110%
not_yet_recruiting550%

Recent Activity

1 active trials
Showing 5 of 10
not_yet_recruitingnot_applicable

R. Officinalis as Pulpotomy Agent in Permanent Teeth With Irreversible Pulpitis

NCT07610057
completednot_applicable

Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA

NCT06880471
not_yet_recruitingnot_applicable

Clinical and Radiographic Evaluation of MTA Pulpotomy Versus Conventional Pulpectomy in Primary Molars With Irreversible Pulpitis

NCT06751316
not_yet_recruitingphase_4

Comparing MTA Pulpotomy to Root Canal Treatment in Management of Permanent Molars With Irreversible Pulpitis in Children

NCT06488131
not_yet_recruitingphase_1

3Mixtatin and MTA Vital Pulpotomy in Primary Molars

NCT06478940
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07610057Not Applicable

R. Officinalis as Pulpotomy Agent in Permanent Teeth With Irreversible Pulpitis

Not Yet Recruiting
NCT06880471Not Applicable

Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA

Completed
NCT06751316Not Applicable

Clinical and Radiographic Evaluation of MTA Pulpotomy Versus Conventional Pulpectomy in Primary Molars With Irreversible Pulpitis

Not Yet Recruiting
NCT06488131Phase 4

Comparing MTA Pulpotomy to Root Canal Treatment in Management of Permanent Molars With Irreversible Pulpitis in Children

Not Yet Recruiting
NCT06478940Phase 1

3Mixtatin and MTA Vital Pulpotomy in Primary Molars

Not Yet Recruiting
NCT06420583Not Applicable

Post Operative Pain and Oral Health Related Quality of Life Following Pulpotomy VS Extraction of Permanent First Molar

Not Yet Recruiting
NCT04345263Not Applicable

Outcome of Full Pulpotomy Using Calcium Silicate Based Materials

Active Not Recruiting
NCT03833557Not Applicable

Success Rate of Three Capping Materials

Completed
NCT03890835Not Applicable

Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA

Unknown
NCT03686475Not Applicable

Is Biodentine, as Successful as, Mineral Trioxide Aggregate

Completed

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10